pcos and glp-1 medications Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy GLP-1 Receptor Agonists May Alleviate

Why it matters: The move threatens telehealth companies compounded GLP-1 weight loss drug sales and benefits brand drugmakers that have pushed against those sales

DOI: 10.1128/CMR.00023-08 12

Complementing these effects, KPV exerts tissue-selective anti-inflammatory activity by inhibiting NF-B signaling, reducing adhesion molecule expression, and suppressing pro-inflammatory cytokines, thereby maintaining a controlled immune environment conducive to repair

As a result, oral GLP-1 drugs are widely viewed as the next major breakthrough for expanding the market

Despite the fact that the exact mechanism by which CagA causes carcinogenesis is still unknown, it is evident that these actions can contribute to raising the chance of developing gastric cancer (48)